share_log

B of A Securities Downgrades IGM Biosciences to Neutral, Announces $8 Price Target

Benzinga ·  Dec 15, 2023 08:39

B of A Securities analyst Geoff Meacham downgrades IGM Biosciences (NASDAQ:IGMS) from Buy to Neutral and announces $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment